Literature DB >> 30710887

Clinical correlates of 9-hole peg test in a large population of people with multiple sclerosis.

Claudio Solaro1, Davide Cattaneo2, Giampaolo Brichetto3, Letizia Castelli4, Andrea Tacchino3, Elisa Gervasoni2, Luca Prosperini5.   

Abstract

OBJECTIVE: To assess the distribution of nine hole peg test (9-HPT) and its clinical correlates in a large sample of patients with multiple sclerosis (MS).
METHODS: Data was collected in a multi-centre, cross-sectional study involving 4 Italians MS centres. We collected demographic and clinical data of 363 patients (244 women, 199 men), including year of symptom onset, disease course, Expanded Disability Status Scale (EDSS).
RESULTS: A total of 206 (61.3%) patients scored ≥2 standard deviations (SDs) of normative values in both hands, while only 38 (11.3%) scored <1 SD from normative values at 9-HPT. We found ceiling and floor effects in mildly (EDSS < 3.0) and severely (EDSS > 6.0) impaired patients. Patients with a primary progressive disease course and those with a more severe disability level showed the large between-hand asymmetry. In multivariate models, predictors of unimanual and bimanual impairments were primary progressive course (odds ratio [OR] = 7.27, p = 0.001) and higher EDSS score (OR = 2.13 for each step, p < 0.001), respectively.
CONCLUSION: We suggest that 9-HPT should be used with caution in patients with low or high disability levels. Between-hand asymmetry and stratification for age, disease course, and presence/absence of bilateral involvement should be taken into account for future study design.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  9-hole peg test; Manual dexterity; Multiple sclerosis

Mesh:

Year:  2019        PMID: 30710887     DOI: 10.1016/j.msard.2019.01.043

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  9 in total

1.  Improving Detection of Change in Motor Functioning in Multiple Sclerosis Using Video-Assisted Composite Measures.

Authors:  Ka-Hoo Lam; Caspar E P van Munster; Marcus D'Souza; Saskia Steinheimer; Christian P Kamm; Jessica Burggraaff; Matthew Johnson; Yordan Zaykov; Jonas Dorn; Frank Dahlke; Ludwig Kappos; Joep Killestein; Bernard Uitdehaag
Journal:  Int J MS Care       Date:  2022-06-20

Review 2.  An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis.

Authors:  Katherine Hope Kenyon; Frederique Boonstra; Gustavo Noffs; Helmut Butzkueven; Adam P Vogel; Scott Kolbe; Anneke van der Walt
Journal:  Cerebellum       Date:  2022-06-27       Impact factor: 3.648

3.  Remote, Unsupervised Functional Motor Task Evaluation in Older Adults across the United States Using the MindCrowd Electronic Cohort.

Authors:  Andrew Hooyman; Joshua S Talboom; Matthew D DeBoth; Lee Ryan; Matthew J Huentelman; Sydney Y Schaefer
Journal:  Dev Neuropsychol       Date:  2021-10-06       Impact factor: 2.113

4.  Italian validation of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ).

Authors:  Andrea Tacchino; Michela Ponzio; Ludovico Pedullà; Jessica Podda; Margherita Monti Bragadin; Elisabetta Pedrazzoli; Giovanna Konrad; Mario Alberto Battaglia; Lidwine Mokkink; Giampaolo Brichetto
Journal:  Neurol Sci       Date:  2020-05-12       Impact factor: 3.307

5.  Upper Limb Dexterity in Patients with Multiple Sclerosis: An Important and Underrated Morbidity.

Authors:  Ricardo N Alonso; Maria B Eizaguirre; Leila Cohen; Cecilia Quarracino; Berenice Silva; Maria C Pita; Cecilia Yastremiz; Sandra Vanotti; Orlando Garcea
Journal:  Int J MS Care       Date:  2020-05-15

6.  The association between cognition and motor performance is beyond structural damage in relapsing-remitting multiple sclerosis.

Authors:  Damiano Mistri; Laura Cacciaguerra; Loredana Storelli; Alessandro Meani; Claudio Cordani; Maria A Rocca; Massimo Filippi
Journal:  J Neurol       Date:  2022-03-12       Impact factor: 6.682

7.  Oral Cladribine in Patients who Change From First-Line Disease Modifying Treatments for Multiple Sclerosis: Protocol of a Prospective Effectiveness and Safety Study (CLAD CROSS).

Authors:  Georgios Tsivgoulis; Spyros Deftereos; Claudio Gobbi; Elisabeth Gulowsen Celius; Alina Kulakowska; Giorgia Maniscalco; Irene Mendes; Nicolaos Grigoriadis
Journal:  J Cent Nerv Syst Dis       Date:  2022-04-01

Review 8.  Measuring Treatment Response in Progressive Multiple Sclerosis-Considerations for Adapting to an Era of Multiple Treatment Options.

Authors:  Nik Krajnc; Thomas Berger; Gabriel Bsteh
Journal:  Biomolecules       Date:  2021-09-10

9.  A Descriptive Correlational Study to Evaluate Three Measures of Assessing Upper Extremity Function in Individuals with Multiple Sclerosis.

Authors:  Aman Saini; Audrey Zucker-Levin; Benjamin McMillan; Pawan Kumar; Sarah Donkers; Michael C Levin
Journal:  Mult Scler Int       Date:  2021-06-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.